{"entity":{"type":"insider","cik":"0001577650","url":"/insider/0001577650","json_url":"/insider/0001577650.json","name":"Celgene European Investment Co LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2013-06-06","last":"2019-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Celgene European Investment Co LLC","source":"filing","n_filings":9,"first_seen":"2013-06-06","last_seen":"2019-11-14"}],"transactions":[{"id":8116084,"accession":"0001104659-19-064171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-064171","line_url":"/filing/0001104659-19-064171#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene European Investment Co LLC; Celgene Alpine Investment Co., LLC; Celgene Switzerland LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":403225.0,"shares_display":"403,225","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":12499975.0,"total_display":"12,499,975.00","total_whole":"12,499,975","shares_owned_after":1777824.0,"shares_owned_after_display":"1,777,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-14","scope":"insider"},{"id":9270523,"accession":"0001209191-18-006131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-006131","line_url":"/filing/0001209191-18-006131#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene Alpine Investment Co., LLC; Celgene European Investment Co LLC; Celgene Switzerland LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":851154.0,"shares_display":"851,154","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":57027318.0,"total_display":"57,027,318.00","total_whole":"57,027,318","shares_owned_after":1374599.0,"shares_owned_after_display":"1,374,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-31","scope":"insider"},{"id":6232371,"accession":"0001209191-18-004895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-004895","line_url":"/filing/0001209191-18-004895#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"Celgene Switzerland LLC; Celgene Alpine Investment Co., LLC; CELGENE CORP /DE/; Celgene European Investment Co LLC","owner_display_name":"Celgene Switzerland LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":851154.0,"shares_display":"851,154","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":57027318.0,"total_display":"57,027,318.00","total_whole":"57,027,318","shares_owned_after":1374599.0,"shares_owned_after_display":"1,374,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-23","scope":"insider"},{"id":4777701,"accession":"0001209191-17-027983","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-027983","line_url":"/filing/0001209191-17-027983#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"Celgene Alpine Investment Co., LLC; CELGENE CORP /DE/; Celgene Switzerland LLC; Celgene European Investment Co LLC","owner_display_name":"Celgene Alpine Investment Co., LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":624575.0,"shares_display":"624,575","price_per_share":49.5,"price_display":"49.50","price_state":"stated","total_value":30916462.5,"total_display":"30,916,462.50","total_whole":"30,916,463","shares_owned_after":1856353.0,"shares_owned_after_display":"1,856,353","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-24","scope":"insider"},{"id":7020585,"accession":"0001209191-14-076273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-076273","line_url":"/filing/0001209191-14-076273#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001577650","owner_name":"Celgene European Investment Co LLC","owner_display_name":"Celgene European Investment Co LLC","owner_url":"/insider/0001577650","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":228645.0,"shares_display":"228,645","price_per_share":110.75,"price_display":"110.75","price_state":"stated","total_value":25322433.75,"total_display":"25,322,433.75","total_whole":"25,322,434","shares_owned_after":1231778.0,"shares_owned_after_display":"1,231,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-17","scope":"insider"},{"id":6614377,"accession":"0001209191-14-029869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-029869","line_url":"/filing/0001209191-14-029869#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"Celgene European Investment Co LLC; Celgene Alpine Investment Co., LLC; CELGENE CORP /DE/","owner_display_name":"Celgene European Investment Co LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294800.0,"shares_display":"294,800","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":12971200.0,"total_display":"12,971,200.00","total_whole":"12,971,200","shares_owned_after":1003133.0,"shares_owned_after_display":"1,003,133","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-29","filed_date":"2014-04-30","scope":"insider"},{"id":6754864,"accession":"0001209191-14-009116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-009116","line_url":"/filing/0001209191-14-009116#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene European Investment Co LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":340000.0,"shares_display":"340,000","price_per_share":29.25,"price_display":"29.25","price_state":"stated","total_value":9945000.0,"total_display":"9,945,000.00","total_whole":"9,945,000","shares_owned_after":3674640.0,"shares_owned_after_display":"3,674,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-11","scope":"insider"},{"id":5337202,"accession":"0001209191-13-038260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-038260","line_url":"/filing/0001209191-13-038260#line-3","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene European Investment Co LLC; Celgene Alpine Investment Co., LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":708333.0,"shares_display":"708,333","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":12749994.0,"total_display":"12,749,994.00","total_whole":"12,749,994","shares_owned_after":708333.0,"shares_owned_after_display":"708,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-29","filed_date":"2013-07-30","scope":"insider"},{"id":4304149,"accession":"0001209191-13-030969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-030969","line_url":"/filing/0001209191-13-030969#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene European Investment Co LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66666.0,"shares_display":"66,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":999990.0,"total_display":"999,990.00","total_whole":"999,990","shares_owned_after":3334640.0,"shares_owned_after_display":"3,334,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Ten percent owner","n_filings":7,"first_seen":"2013-07-30","last_seen":"2019-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Ten percent owner","n_filings":2,"first_seen":"2013-06-06","last_seen":"2014-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001577650","retrieved_at":"2026-08-22T23:11:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}